Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANAGLIFLOZIN for Hyperglycaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 35 adverse event reports in the FDA FAERS database where CANAGLIFLOZIN was used for Hyperglycaemia.

Most Reported Side Effects for CANAGLIFLOZIN

Side Effect Reports % Deaths Hosp.
Diabetic ketoacidosis 3,413 14.0% 67 2,837
Toe amputation 2,193 9.0% 19 1,647
Osteomyelitis 2,146 8.8% 20 1,807
Acute kidney injury 1,853 7.6% 69 1,595
Fungal infection 1,385 5.7% 3 63
Gangrene 1,081 4.4% 14 952
Weight decreased 1,014 4.2% 13 150
Cellulitis 1,007 4.1% 9 887
Urinary tract infection 920 3.8% 16 318
Diabetic foot infection 832 3.4% 8 755
Leg amputation 792 3.2% 23 668
Diabetic foot 787 3.2% 9 663
Blood glucose increased 777 3.2% 6 162
Off label use 724 3.0% 15 272
Ketoacidosis 641 2.6% 11 272

Other Indications for CANAGLIFLOZIN

Type 2 diabetes mellitus (10,795) Product used for unknown indication (8,748) Diabetes mellitus (3,397) Type 1 diabetes mellitus (422) Diabetes mellitus management (257) Diabetes mellitus inadequate control (121) Blood glucose increased (85) Glycosylated haemoglobin increased (55) Weight decreased (46) Blood glucose abnormal (39)

Other Drugs Used for Hyperglycaemia

METFORMIN (373) INSULIN GLARGINE (198) INSULIN NOS (87) INSULIN HUMAN (85) DAPAGLIFLOZIN (70) INSULIN ASPART (69) EMPAGLIFLOZIN (67) INSULIN LISPRO (61) MIFEPRISTONE (52) GLIMEPIRIDE (43)

Related Pages

CANAGLIFLOZIN Full Profile All Hyperglycaemia Drugs CANAGLIFLOZIN Demographics CANAGLIFLOZIN Timeline